PARIS — The oral multiple sclerosis (MS) drug fingolimod (Gilenya, Novartis) has shown impressive results in the pediatric population, with large reductions in relapse rate, new MRI lesions, brain ...

BUFFALO, N.Y. -- A study by researchers in the University at Buffalo's Pediatric Multiple Sclerosis Center of Excellence has produced the first examination of deficits in pediatric patients with ...

BUFFALO, N.Y. -- The Jacobs Neurological Institute of the University at Buffalo has received a $1.8 million, five-year grant from the National Multiple Sclerosis Society to establish at Women & ...

Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, discusses the current body of data on treating pediatric multiple sclerosis (MS) ...

University of Alabama at Birmingham (UAB) School of Nursing Instructor Yolanda Wheeler, MSN, CRNP, CPNP-AC, wants to know how Multiple Sclerosis (MS) impacts decision-making in children. Using a ...

MS usually strikes women in their mid-30s or 40s Only about 8%2C000 children have the disease worldwide Drug companies are poised to begin the first clinical trials in children BOSTON — Two years ago, ...

NEW YORK, NY... 'Pediatric Multiple Sclerosis and Related Disorders' has just been published by the International Pediatric MS Study Group as a supplement to the journal Neurology. The Group was ...

Rates of autoimmune diseases, including thyroid disorders and multiple sclerosis (MS), are higher among families of patients with pediatric MS compared with unaffected families, new research suggests.

Please provide your email address to receive an email when new articles are posted on . The 2-year follow-up also showed similar findings in adults with MS, O’Neill, a pediatric neuroimmunology fellow ...

“For the first time, we have an FDA-approved treatment specifically for children and adolescents with multiple sclerosis,” explains Billy Dunn, M.D., director of the Division of Neurology Products in ...

Pediatric-onset MS requires specialized care due to unique clinical features like cognitive issues and motor impairment. Unstructured transitions from pediatric to adult care lead to treatment delays, ...

Recent research has shed new light on multiple sclerosis (MS) in children, who make up about 3% to 5% of the MS population. At one time, children were thought to not experience disability due to their ...